Envoy Medical, Inc.
COCH
$1.48
$0.021.37%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 22.52% | -51.00% | 37.05% | -28.09% | -432.54% |
| Total Depreciation and Amortization | -2.04% | 16.67% | 23.53% | -29.17% | 65.52% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -92.55% | 238.41% | -189.04% | 855.50% | 95.81% |
| Change in Net Operating Assets | -187.22% | 187.34% | 133.89% | 82.23% | -245.71% |
| Cash from Operations | -56.32% | 42.81% | 16.05% | 47.55% | -1,114.10% |
| Capital Expenditure | 146.15% | -366.53% | -127.52% | -419.05% | 66.13% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 200.00% | -- | -- | -- |
| Cash from Investing | 186.83% | 22.15% | -624.77% | -419.05% | 66.13% |
| Total Debt Issued | -33.33% | 200.00% | -50.00% | -- | -100.00% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -100.00% | 1,444.04% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 66.50% | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -100.00% |
| Cash from Financing | -19.46% | 144.04% | -62.59% | 559.63% | -109.24% |
| Foreign Exchange rate Adjustments | -100.00% | 0.00% | 0.00% | 50.00% | -100.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -60.46% | 183.71% | -540.03% | 105.76% | -175.26% |